‘It’s almost like a career’: Dana-Farber breast cancer patient shares her story


A Dana-Farber clinical trial of a so-called antibody-drug conjugates shows promising results for a Roxbury resident battling metastatic breast cancer.

Previous BayCare names new president of St. Joseph's Hospital
Next Norton opens new $16M children’s campus on former Kmart site